Recurrence of renal cell carcinoma after simultaneous radical nephrectomy and cadaver renal transplant

被引:1
作者
Inoue, Shinya [1 ]
Shioya, Akihiro [2 ]
Kunii, Kenshirou [1 ]
Suga, Kodai [1 ]
Morita, Nobuyo [1 ]
Chikazawa, Ippei [1 ]
Tanaka, Tatsuro [1 ]
Miyazawa, Katsuhito [1 ]
机构
[1] Kanazawa Med Univ, Dept Urol, Uchinada, Ishikawa 9200293, Japan
[2] Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan
关键词
immunosuppressive agents; kidney transplantation; radical nephrectomy; recurrence; renal cell carcinoma; CANCER; RISK;
D O I
10.1002/iju5.12499
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Generally, renal transplantation is contraindicated in cancer patients, and a certain follow-up period is required. We report a case of late recurrence of renal cell carcinoma in a patient who underwent simultaneous radical nephrectomy and cadaver renal transplantation due to renal cell carcinoma observed during renal transplantation after 12 years. Case presentation: Incidental renal cell carcinoma was found in a 48-year-old man during kidney transplantation who subsequently underwent simultaneous cadaver kidney transplantation and radical nephrectomy. Twelve years after transplantation, he developed an anterior mediastinal tumor, a lung tumor which was resected and a right adrenal gland mass which was resected along with the right kidney. Currently, he is being treated with tyrosine kinase inhibitors owing to the metastasis in the left adrenal gland. Conclusion: In patients with metastatic carcinoma undergoing renal transplant, the indications for surgical procedures and choice of immunosuppressants should be carefully considered.
引用
收藏
页码:397 / 400
页数:4
相关论文
共 12 条
[1]   KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation [J].
Chadban, Steven J. ;
Ahn, Curie ;
Axelrod, David A. ;
Foster, Bethany J. ;
Kasiske, Bertram L. ;
Kher, Vijah ;
Kumar, Deepali ;
Oberbauer, Rainer ;
Pascual, Julio ;
Pilmore, Helen L. ;
Rodrigue, James R. ;
Segev, Dorry L. ;
Sheerin, Neil S. ;
Tinckam, Kathryn J. ;
Wong, Germaine ;
Knoll, Gregory A. .
TRANSPLANTATION, 2020, 104 (04) :S11-S103
[2]   Cyclosporine induces cancer progression by a cell-autonomous mechanism [J].
Hojo, M ;
Morimoto, T ;
Maluccio, M ;
Asano, T ;
Morimoto, K ;
Lagman, M ;
Shimbo, T ;
Suthanthiran, M .
NATURE, 1999, 397 (6719) :530-534
[3]  
Kasiske Bertram L, 2001, Am J Transplant, V1 Suppl 2, P3
[4]   A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients [J].
Lim, W. H. ;
Eris, J. ;
Kanellis, J. ;
Pussell, B. ;
Wiid, Z. ;
Witcombe, D. ;
Russ, G. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (09) :2106-2119
[5]   The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine [J].
Lim, Wai H. ;
Russ, Graeme R. ;
Wong, Germaine ;
Pilmore, Helen ;
Kanellis, John ;
Chadban, Steven J. .
KIDNEY INTERNATIONAL, 2017, 91 (04) :954-963
[6]   One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease [J].
Neeff, Hannes Philipp ;
Pisarski, Przemyslaw ;
Tittelbach-Helmrich, Dietlind ;
Karajanev, Konstantin ;
Neumann, Hartmut P. H. ;
Hopt, Ulrich Theodor ;
Drognitz, Oliver .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (02) :466-471
[7]   Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease [J].
Patel, P. ;
Horsfield, C. ;
Compton, F. ;
Taylor, J. ;
Koffman, G. ;
Olsburgh, J. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (05) :391-395
[8]  
Pham Phuong-Thu, 2010, Semin Dial, V23, P595, DOI 10.1111/j.1525-139X.2010.00809.x
[9]  
Schrock W, 2021, J UROLOGY, V206, pE647
[10]   Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient [J].
Sherston, Sam N. ;
Carroll, Robert P. ;
Harden, Paul N. ;
Wood, Kathryn J. .
TRANSPLANTATION, 2014, 97 (06) :605-611